Perbedaan Merck Tbk. dan Trimegah Bangun Persada Tbk.: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Trimegah Bangun Persada Tbk. diperdagangkan di Rp840 (kapitalisasi pasar 52,69 T, volume 24 jam 53,38 jt). Perbedaan utamanya: Trimegah Bangun Persada Tbk. jauh lebih besar — sekitar 31× kapitalisasi pasar Merck Tbk., dan Trimegah Bangun Persada Tbk. lebih aktif diperdagangkan (53,38 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | NCKL | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 52,69 T |
Volume | 37,6 rb | 53,38 jt |
Lot | 376 | 533,77 rb |
Perputaran | 144,47 jt | 45,04 M |
Harga Rata-rata | 3.842,23 | 843,75 |
Nilai Transaksi | 144,47 jt | 45,04 M |
Harga Ekuilibrium Indikatif | 3.840 | 840 |
Volume Ekuilibrium Indikatif | 7 | 63,41 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.
Selengkapnya di halaman NCKL →